XTX Topco’s LYRA THERAPEUTICS INC LYRA Stock Holding History

XTX Topco’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-356	Closed	-$4.57K	–	2670
2024 Q3	$4.57K	Sell	356 -323	-48%	-$4.75K	﹤0.01%	1981
2024 Q2	$9.39K	Buy	+679	New	+$76.8K	﹤0.01%	1694

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's LYRA Position: Q4 2024 in Review

XTX Topco sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2024, closing a stake of 356 shares — an estimated $4.57K sold.

XTX Topco first reported a position in LYRA in Q2 2024 and held it in 2 quarters. The position peaked at $9.39K in Q2 2024. 54 funds tracked by Wall St. Rank hold LYRA as of Q4 2024.

XTX Topco reported no remaining LYRA THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
XTX Topco sold 356 LYRA THERAPEUTICS INC shares in Q4 2024, an estimated $4.57K.
XTX Topco first reported a position in LYRA THERAPEUTICS INC in Q2 2024 and held it in 2 quarters.
XTX Topco's LYRA THERAPEUTICS INC position peaked at $9.39K in Q2 2024.
54 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.